<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158873/" ref="ordinalpos=728&amp;ncbi_uid=6644607&amp;link_uid=PMC4158873" image-link="/pmc/articles/PMC4158873/figure/F3/" class="imagepopup">Figure 3.  From: O-GlcNAcylation and Metabolic Reprograming in Cancer. </a></div><br /><div class="p4l_captionBody"><b>PI3K/Akt/mTOR signaling pathway</b>. mTORC1 is activated by receptor signaling through the PI3K/Akt pathway. mTORC2 is crucial factor in PI3K/Akt signaling, phosphorylating Akt on Ser473 to promote its maximal activation. mTOR regulates protein O-GlcNAcylation through affecting OGT stability. Several proteins of PI3K/Akt/mTOR pathway are modified by OGT, i.e., PI3K, PDK1, and Akt.</div></div>